Nephrogenic rests and nephroblastomatosis: literature review and clinical reports
https://doi.org/10.21682/2311-1267-2020-7-3-119-124
Abstract
Nephrogenic rests and nephroblastomatosis describe persistence of embryonic renal parenchyma (metanephric blastema) beyond 36 weeks of gestation, when nephrogenesis is normally complete. This persistent metanephric blastema may transform into the Wilms tumor, and are detected in 30–40 % of unilateral nephroblstoma and nearly 100 % in bilateral cases. The risk of Wilms tumour is increased in any type of nephrogenic rests/nephroblastomatosis but it is higher in infants and in patients with intralobar nephrogenic rests. We cite below several studies described different types of nephrogenic rests, their connection with nephroblastoma development and the details of diagnostic. We refer to clinical examples, in that regard. Two cases are presented: bilateral diffuse hyperplastic perilobar nephroblastomatosis in one child and an infant with combination of perilobar nephrogenic rests in one kidney and Wilms tumour in the other kidney.
About the Authors
L. I. ShatsRussian Federation
Pediatric Oncologist, Assistant at the Department of Oncology, Pediatric Oncology and Radiotherapy at theSt. PetersburgStatePediatricMedicalUniversity
2 Litovskaya St., S.-Petersburg, 19410,
68А Leningradskaya St., Pesochny, S.-Petersburg, 197758
B. V. Kondratiev
Russian Federation
Radiologist
12A Tipanova St., S.-Petersburg, 196135
M. B. Belogurova
Russian Federation
Dr. of Sci. (Med.), Professor, Head of the Department of Oncology, Pediatric Oncology and Radiotherapy at theSt. PetersburgStatePediatricMedicalUniversity, Head of Children’s Oncology Department at the Saint Petersburg Clinical Scientific and Practical Center of Specialized Medical Assistance (Oncological)
2 Litovskaya St., S.-Petersburg, 19410,
68А Leningradskaya St., Pesochny, S.-Petersburg, 197758
References
1. Beckwith J.B., Kiviat N.B., Bonadio J.F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 1990;10(1–2):1–36. https://doi.org/10.3109/15513819009067094.
2. Beckwith J.B. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 1998;79:268–73. doi: 10.1002/(sici)10968628(19981002)79:4%3C268::aid-ajmg7%3E3.0.co;2-i.
3. Beckwith J.B. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 1993;21(3):158–68. doi: 10.1002/mpo.2950210303.
4. Breslow N.E., Beckwith J.B., Perlman E.J., Reeve A.E. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 2006;47:260–7. doi: 10.1002/pbc.20891.
5. Fukuzawa R., Reeve A.E. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol 2007;29(9):589–94. doi: 10.1097/01.mph.0000212981.67114.
6. Perlman E.J., Faria P., Soares A., Hoffer F., Sredni S., Ritchey M., Shamberger R.C., Green D., Beckwith J.B. Hyperplastic perilobar nephroblastomatosis: long term survival of 52 patients. Pediatr Blood Cancer 2006;26:203–21. doi: 10.1002/pbc.20386.
7. Heller M.T., Haarer K.A., Thomas E., Thaete F.L. Neoplastic and proliferative disorders of the perinephric space. Clin Rad 2012;67:e31–41. doi: 10.1016/j.crad.2012.03.015.
8. Vujanić G.M., Apps J.R., Moroz V., Ceroni F., Williams R.D., Sebire N.J., Pritchard-Jones K. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience. Pediatr Blood Сancer 2017;64:e26547. doi: 10.1002/pbc.26547.
9. Kachanov D.Yu., Mitrofanova A.M., Shcherbakov A.P., Shamanskaya T.V., Merkulov N.N., Tereshchenko G.V., Varfolomeeva S.R. Hyperplastic perilobal nephrogenic rests of the left kidney: the difficulty of differential diagnosis. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology 2016;3(1):67–9. (In Russ.). doi: 10.17650/2311-1267-2016-3-1-67-69.
10. Kim S.H. Radiology Illustrated Uroradiology, 2012. P. 342. doi: 10.1007/978-3-642-05322-1.
11. Grattan-Smith J.D. Nephroblastomatosis: imaging challenges. Pediatr Radiol 2011;41(Suppl 1):198. doi: 10.1007/s00247-011-1997-3.
12. Lowe L.H., Isuani B.H., Heller R.M., Stein S.M., Johnson J.E., Navarro O.M., Hernanz-Schulman M. Pediatric renal masses: Wilms tumor and beyond. Radiographics 2000;20(6):1585–603 doi: 10.1148/radiographics.20.6.g00nv051585.
13. Coppes M.J., Arnold M., Beckwith J.B., Ritchey M.L., D’Angio G.J., Green D.M., Breslow N.E. Factors affecting the risk of contralateral Wilms tumor development. Cancer 1999;85:1616–25. doi: 10.1002/(sici)1097-0142(19990401)85:7<1616::aid-cncr26>3.0.co;2-4.
14. Ortiz M.V., Fernandez-Ledon S., Ramaswamy K., Shukla N.N., Kobos R., Heaton T.E., LaQuaglia M.P. Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis. Pediatr Blood Cancer 2019;66:e27500. doi: 10.1002/pbc.27500.
Review
For citations:
Shats L.I., Kondratiev B.V., Belogurova M.B. Nephrogenic rests and nephroblastomatosis: literature review and clinical reports. Russian Journal of Pediatric Hematology and Oncology. 2020;7(3):119-124. (In Russ.) https://doi.org/10.21682/2311-1267-2020-7-3-119-124